FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Eprosartan Mesylate Tablets
Status: Currently in Shortage
»Date first posted: 03/11/2019
»Therapeutic Categories: Cardiovascular

Mylan Pharmaceuticals Inc. (Reverified 01/21/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Eprosartan Mesylate 600mg T 30s (NDC 0378-6629-93) Out of stock. Resupply TBD Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English